THC-O-acetate (THC-O)

What THC-O-acetate is

THC-O-acetate is the O-acetyl ester of Δ9-THC: the free hydroxyl group on the THC molecule is replaced with an acetate group (–OCOCH₃) Strong evidence^[1]. It is a semi-synthetic compound—not a naturally occurring terpene or minor cannabinoid—and is produced by reacting THC (typically converted from hemp-derived CBD) with acetic anhydride.

The compound was first synthesized in the mid-20th century. The US Army's Edgewood Arsenal studied it as a potential incapacitating agent during the 1940s–1970s. It re-emerged commercially around 2020–2021 in the US 'hemp-derived cannabinoid' market, where chemists used acetic anhydride to acetylate Δ8-THC or Δ9-THC made from hemp CBD, and sold the result in vape carts, edibles, and tinctures.

As an ester, THC-O is thought to be a prodrug: it is believed to be hydrolyzed to active THC after ingestion, with the acetate group cleaved off by esterases in the body or gastrointestinal tract Weak / limited^[1]. This hydrolysis is the biochemical basis for claims that it is 'stronger' than THC, but published human pharmacokinetic data are extremely limited.

Where it's found

THC-O-acetate is not a natural constituent of cannabis at any concentration that has been reliably measured in peer-reviewed phytochemical surveys Strong evidence. Every commercial source is synthetic. This contrasts sharply with minor natural cannabinoids like CBG or THCV, which are biosynthesized by the plant during flower development.

In the consumer market, THC-O appears exclusively in manufactured products:

• Vape cartridges (highest hazard due to thermal decomposition; see Safety section)
• Gummies and other edibles
• Tinctures and oils
• Distillate blends, sometimes mixed with Δ8-THC, HHC, or other synthetic cannabinoids without clear labeling^[2]

Products are typically unregulated, not tested for contaminants, and often mislabeled regarding potency and purity.

Aroma and sensory profile

THC-O-acetate itself has no characteristic aroma comparable to terpenes No data. It is a viscous oil with minimal volatile properties at room temperature. When present in consumer products—especially vape carts—the perceived smell is almost entirely driven by whatever terpenes (often botanical or re-introduced cannabis-derived terpenes) and residual solvents are added during formulation.

There is no 'THC-O smell' in the way there is a Limonene or Pinene smell. Users cannot reliably identify THC-O products by aroma alone.

Effects: what evidence actually shows

Marketing and user forums commonly claim THC-O is '3 times stronger than THC' and produces 'psychedelic' or 'spiritual' effects. Here is what the evidence supports:

Potency and strength comparisons: There are no published controlled human dosing studies of THC-O-acetate No data. The '3 times stronger' figure traces to anecdotal user reports and animal studies from the 1970s–1980s of uncertain quality and unclear dose equivalence Anecdote. It should not be treated as established clinical evidence.

'Psychedelic' or 'spiritual' character: These effects are reported anecdotally in online forums and user reviews Anecdote. There is no clinical confirmation, and no proposed mechanism distinct from CB1 receptor agonism has been demonstrated. Standard CB1 agonists (including high-dose THC) can produce anxiety, dissociation, and perceptual distortion; there is no reason to expect THC-O to differ qualitatively once hydrolyzed to THC.

Delayed onset: Users consistently report a longer time-to-peak effect (20–60 minutes even when vaped, and 45–120 minutes when eaten) compared to smoked THC Anecdote. This timing is consistent with prodrug hydrolysis—the acetate must first be removed by esterases before THC exerts its effects—but has not been rigorously characterized in humans.

Intoxication and impairment: Once metabolized to THC, THC-O should behave pharmacologically like a potent THC agonist. Users report THC-like intoxication, impairment of coordination and cognition, increased heart rate, anxiety risk, and red eyes Weak / limited^[3]. There is no good reason to expect the subjective or objective effects to be fundamentally different from those of standard THC after acetate hydrolysis occurs.

Safety: ketene and vaping risk

The most important safety fact about THC-O is a chemistry fact. When acetate esters of cannabinoids—THC-O-acetate and CBN-O-acetate—are heated to vaping temperatures (typically 180–220 °C), they undergo thermal degradation that produces ketene (CH₂=C=O), a highly toxic gas that causes severe, delayed lung injury Strong evidence.

In 2023, researchers Meehan-Atrash and colleagues published peer-reviewed evidence demonstrating ketene formation from THC-O-acetate and CBN-O-acetate under typical vaporizer conditions Strong evidence. Ketene is a well-characterized chemical hazard: it reacts with lung proteins and causes acute inflammation, fibrosis, and bronchiolitis obliterans—a condition characterized by scarring and narrowing of the small airways. This is mechanistically similar to the way vitamin E acetate was implicated in the 2019–2020 EVALI (e-cigarette or vaping product use-associated lung injury) outbreak Strong evidence.

The risk is specific to inhalation and vaping. Oral ingestion does not involve pyrolysis and does not generate ketene, though it carries the ordinary risks of any potent, unregulated cannabinoid product: overconsumption, contamination, inaccurate labeling, and the possibility of unexpected drug interactions.

Harm reduction: If someone chooses to use THC-O, the chemistry-based recommendation is clear: do not vape it. Edibles or tinctures carry chemical hazards but not the specific ketene risk. No THC-O product should be used by pregnant individuals, nursing individuals, or minors.

Legal status

In February 2023, the US DEA issued a letter stating that Δ8-THC-O and Δ9-THC-O do not occur naturally in cannabis and therefore cannot be considered hemp-derived under the 2018 Farm Bill—making them controlled substances under the Controlled Substances Act. Some industry attorneys have disputed this interpretation in court filings, and litigation is ongoing in some jurisdictions.

State laws vary widely. Several states have explicitly banned THC-O along with other synthetic or semi-synthetic cannabinoids; others have no specific rule. Possession, sale, and distribution penalties range from civil fines to felony charges depending on jurisdiction and quantity.

Check current local and state law before assuming anything about legality.

Related synthetic and semi-synthetic cannabinoids

THC-O is part of a growing family of semi-synthetic and fully synthetic cannabinoids that entered the US hemp-derived market after the 2018 Farm Bill:

• Δ8-THC: An isomer of THC; typically made by isomerizing hemp-derived CBD or Δ9-THC. Less studied in humans than Δ9-THC; likely similar potency and effects.
• HHC: Hydrogenated THC analog, created by adding hydrogen to the THC molecule. Circulating potency and safety claims lack rigorous human evidence.
• HHC-O: The acetate ester of HHC. Carries the same ketene risk when vaped as THC-O and CBN-O.
• CBN-O-acetate: The acetate ester of cannabinol (CBN); also produces ketene under vaping conditions.
• CBG: A naturally occurring minor cannabinoid in the cannabis plant; included for comparison as a legitimate, non-synthetic compound.

All of these semi-synthetic or fully synthetic products operate in a largely unregulated market with minimal human safety and efficacy data.

Sources

How this page was made

Related

• Carboxy-THC — The inactive THC metabolite that shows up in drug tests, not a terpene or plant compound.
• Delta-3-Carene — A piney monoterpene present in trace amounts across many cannabis strains, with limited hu...
• Flavonoids in Cannabis — Non-volatile plant pigments with minimal human research and widespread marketing claims.
• Limonene — Citrus monoterpene with weak evidence for anxiety relief in cannabis contexts.
• Sesquiterpenes — 15-carbon terpenes that give cannabis its woody, spicy, and earthy notes.